gallic acid has been researched along with Palmoplantaris Pustulosis in 6 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psoriasis is an inflammation of the skin mediated via the IL-23/Thl17/IL-17 pathway." | 5.91 | Gallic acid diminishes pro-inflammatory interferon-γ- and interleukin-17-producing sub-populations in vitro in patients with psoriasis. ( Apostolopoulou, K; Bogdanos, DP; Dardiotis, E; Grammatikopoulou, MG; Mavropoulos, A; Tsiogkas, SG; Zafiriou, E, 2023) |
| "Gallic Acid (GA) has shown efficacious results against the hyperproliferation of keratinocytes while lipid-polymer loaded hybrid nanoparticles (LPHNs) have an edge over lipidic and polymeric nanoparticles considering drug loading, controlled release, stability, and retention." | 5.91 | Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis. ( Abourehab, MAS; Hazari, SA; Kesharwani, P; Sheikh, A; Tulbah, AS, 2023) |
| "Psoriasis is a deleterious auto-immune disorder which seriously harms the patients physical and mental health." | 5.91 | Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis. ( Alshehri, SA; Hazari, SA; Kesharwani, P; Molugulu, N; Sahebkar, A; Sheikh, A; Wahab, S, 2023) |
| "These results indicated that the astilbin-gallic acid microemulsion might be a potential topical drug used for the treatment of psoriasis." | 4.31 | Optimization of the Transdermal Delivery System in Astilbin Microemulsion with Improved Stability and Anti-psoriatic Activity. ( Ding, Y; Liu, L; Wang, Y; Wu, Y; Zhao, R, 2023) |
| "Psoriasis is an inflammation of the skin mediated via the IL-23/Thl17/IL-17 pathway." | 1.91 | Gallic acid diminishes pro-inflammatory interferon-γ- and interleukin-17-producing sub-populations in vitro in patients with psoriasis. ( Apostolopoulou, K; Bogdanos, DP; Dardiotis, E; Grammatikopoulou, MG; Mavropoulos, A; Tsiogkas, SG; Zafiriou, E, 2023) |
| "Gallic Acid (GA) has shown efficacious results against the hyperproliferation of keratinocytes while lipid-polymer loaded hybrid nanoparticles (LPHNs) have an edge over lipidic and polymeric nanoparticles considering drug loading, controlled release, stability, and retention." | 1.91 | Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis. ( Abourehab, MAS; Hazari, SA; Kesharwani, P; Sheikh, A; Tulbah, AS, 2023) |
| "Psoriasis is a deleterious auto-immune disorder which seriously harms the patients physical and mental health." | 1.91 | Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis. ( Alshehri, SA; Hazari, SA; Kesharwani, P; Molugulu, N; Sahebkar, A; Sheikh, A; Wahab, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y | 1 |
| Liu, L | 1 |
| Wu, Y | 1 |
| Wang, Y | 1 |
| Zhao, R | 1 |
| Tsiogkas, SG | 1 |
| Apostolopoulou, K | 1 |
| Mavropoulos, A | 1 |
| Grammatikopoulou, MG | 1 |
| Dardiotis, E | 1 |
| Zafiriou, E | 1 |
| Bogdanos, DP | 1 |
| Ortega-Sánchez, C | 1 |
| Pérez-Díaz, MA | 1 |
| Martínez-López, V | 1 |
| Zacaula-Juárez, N | 1 |
| González-Torres, M | 1 |
| Leyva-Gómez, G | 1 |
| Hernandez-Valdepeña, MA | 1 |
| Gimeno, M | 1 |
| Sánchez-Sánchez, R | 1 |
| Hazari, SA | 2 |
| Sheikh, A | 2 |
| Abourehab, MAS | 1 |
| Tulbah, AS | 1 |
| Kesharwani, P | 2 |
| Molugulu, N | 1 |
| Alshehri, SA | 1 |
| Wahab, S | 1 |
| Sahebkar, A | 1 |
| Zhang, J | 1 |
| Li, X | 1 |
| Wei, J | 1 |
| Chen, H | 1 |
| Lu, Y | 1 |
| Li, L | 1 |
| Han, L | 1 |
| Lu, C | 1 |
6 other studies available for gallic acid and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Optimization of the Transdermal Delivery System in Astilbin Microemulsion with Improved Stability and Anti-psoriatic Activity.
Topics: Administration, Cutaneous; Animals; Emulsions; Flavonols; Gallic Acid; Mice; Particle Size; Psoriasi | 2023 |
Gallic acid diminishes pro-inflammatory interferon-γ- and interleukin-17-producing sub-populations in vitro in patients with psoriasis.
Topics: Cytokines; Gallic Acid; Humans; Interferon-gamma; Interleukin-17; Psoriasis | 2023 |
Inhibition of proliferation, migration, and adhesion of skin fibroblasts by enzymatic poly(gallic acid) grafted with L-Arginine, migration, and adhesion of skin fibroblasts by enzymatic poly(gallic acid) grafted with L-Arginine.
Topics: Antioxidants; Arginine; Cell Proliferation; Dermatitis, Atopic; Fibroblasts; Gallic Acid; Gentian Vi | 2023 |
Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis.
Topics: Chitosan; Gallic Acid; Humans; Imiquimod; Lecithins; Nanoparticles; Particle Size; Psoriasis | 2023 |
Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis.
Topics: Chitosan; Gallic Acid; Humans; Hyaluronic Acid; Nanoparticles; Psoriasis | 2023 |
Gallic acid inhibits the expression of keratin 16 and keratin 17 through Nrf2 in psoriasis-like skin disease.
Topics: Animals; Cell Line; Cell Survival; Gallic Acid; Gene Expression Regulation; Humans; Interleukin-17; | 2018 |